Table 4.
Univariate and multivariate Cox regression analyses of risk factors for progression-free survival in Cohort 5.
Univariate HR (95% CI) |
P value | Multivariate HR (95% CI) |
P value | |
---|---|---|---|---|
AFP, ng/ml | ||||
≤ 400 | 1.0 | |||
> 400 | 2.71 (1.69-4.37) | <0.001 | 2.11 (1.29 - 3.48) | 0.003 |
Age | 0.98 (0.96-1) | 0.040 | ||
ALBI grade | ||||
1 | 1.0 | |||
2 | 0.96 (0.59-1.56) | 0.868 | ||
3 | 1.68 (0.84-3.39) | 0.145 | ||
Child-Pugh grade | ||||
A | 1.0 | |||
B+C | 1.09 (0.67-1.78) | 0.728 | ||
Cirrhosis | ||||
Absent | 1.0 | |||
Present | 1.56 (0.88-2.77) | 0.128 | ||
CRP | 1.01 (1-1.01) | 0.001 | 1.01 (1 - 1.01) | 0.048 |
ECOG PS | ||||
0 | 1.0 | |||
1 + 2 | 0.94 (0.61-1.44) | 0.766 | ||
Embolus | ||||
Absent | 1.0 | |||
Present | 0.92 (0.6-1.42) | 0.717 | ||
Aetiology | ||||
HBV | 1.0 | |||
HCV | 1.33 (0.18-9.57) | 0.779 | ||
Others | 1.11 (0.45-2.75) | 0.817 | ||
NLR | 1.15 (1.06-1.25) | 0.001 | ||
RNETS | 3.4 (1.86-6.2) | <0.001 | 2.49 (1.29 - 4.81) | 0.007 |
Gender | ||||
Female | 1.0 | |||
Male | 0.84 (0.43-1.62) | 0.599 | ||
Tumor number | ||||
≤ 3 | 1.0 | |||
> 3 | 1.02 (0.65-1.59) | 0.936 | ||
Tumor size, cm | 1.04 (0.99-1.09) | 0.125 |